{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:30:47Z","timestamp":1786717847724,"version":"build-2736575974"},"reference-count":62,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Hum Reprod Sci"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/0974-1208.192056","type":"journal-article","created":{"date-parts":[[2016,10,12]],"date-time":"2016-10-12T07:06:16Z","timestamp":1476255976000},"page":"164","source":"Crossref","is-referenced-by-count":30,"title":["Gonadotropin-releasing hormone agonist trigger is a better alternative than human chorionic gonadotropin in PCOS undergoing IVF cycles for an OHSS Free Clinic: A Randomized control trial"],"prefix":"10.4103","volume":"9","author":[{"given":"Deepika","family":"Krishna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snehal","family":"Dhoble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautham","family":"Praneesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suvarna","family":"Rathore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Upadhaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamini","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0974-1208.192056-1","first-page":"389","volume-title":"Preventing ovarian hyperstimulation syndrome: Guidance for the clinician","author":"Humaidan","year":"2010","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.192056-2","first-page":"2511","volume-title":"GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: Two prospective randomized controlled multi-centre studies in IVF patients","author":"Humaidan","year":"2013","journal-title":"Hum Reprod"},{"key":"key-10.4103\/0974-1208.192056-3","first-page":"1763","volume-title":"Disappearance rates of endogenous luteinizing hormone and chorionic gonadotropin in man","author":"Yen","year":"1968","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0974-1208.192056-4","first-page":"112","volume-title":"Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles","author":"Papanikolaou","year":"2006","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.192056-5","first-page":"77","volume-title":"Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS)","author":"Delvigne","year":"2003","journal-title":"Hum Reprod Update"},{"key":"key-10.4103\/0974-1208.192056-6","first-page":"559","volume-title":"Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): A review","author":"Delvigne","year":"2002","journal-title":"Hum Reprod Update"},{"key":"key-10.4103\/0974-1208.192056-7","first-page":"377","volume-title":"Ovarian hyperstimulation syndrome: Pathophysiology, staging, prediction and prevention","author":"Nastri","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"key-10.4103\/0974-1208.192056-8","first-page":"249","volume-title":"Ovarian hyperstimulation syndrome in novel reproductive technologies: Prevention and treatment","author":"Navot","year":"1992","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.192056-9","first-page":"398","volume-title":"Disappearance of exogenously administered human chorionic gonadotropin","author":"Damewood","year":"1989","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.192056-10","first-page":"709","volume-title":"Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization","author":"Fauser","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0974-1208.192056-11","first-page":"1213","volume-title":"GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF\/ICSI cycles: A prospective randomized study","author":"Humaidan","year":"2005","journal-title":"Hum Reprod"},{"key":"key-10.4103\/0974-1208.192056-12","first-page":"510","volume-title":"GnRH agonist for triggering of final oocyte maturation: Time for a change of practice?","author":"Humaidan","year":"2011","journal-title":"Hum Reprod Update"},{"key":"key-10.4103\/0974-1208.192056-13","first-page":"554","volume-title":"The effect of luteal phase vaginal estradiol supplementation on the success of in vitro fertilization treatment: A prospective randomized study","author":"Engmann","year":"2008","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.192056-14","first-page":"1","volume-title":"Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome","author":"Kol","year":"2004","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.192056-15","first-page":"274","volume-title":"GnRHa trigger for final oocyte maturation: Is HCG trigger history?","author":"Humaidan","year":"2014","journal-title":"Reprod Biomed Online"},{"key":"key-10.4103\/0974-1208.192056-16","first-page":"2029","volume-title":"Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a \"freeze-all\" strategy: A prospective multicentric study","author":"Griesinger","year":"2011","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.192056-17","first-page":"151","volume-title":"Management of ovarian hyperstimulation syndrome.Produced on behalf of the BFS Policy and Practice Committee","author":"Tan","year":"2013","journal-title":"Hum Fertil (Camb)"},{"key":"key-10.4103\/0974-1208.192056-18","first-page":"175","volume-title":"Odds of ovarian hyperstimulation syndrome (OHSS)-time for reassessment","author":"Mocanu","year":"2007","journal-title":"Hum Fertil (Camb)"},{"key":"key-10.4103\/0974-1208.192056-19","first-page":"792","volume-title":"Early and late presentation of the ovarian hyperstimulation syndrome: Two distinct entities with different risk factors","author":"Lyons","year":"1994","journal-title":"Hum Reprod"},{"key":"key-10.4103\/0974-1208.192056-20","first-page":"901","volume-title":"Distinction between early and late ovarian hyperstimulation syndrome","author":"Mathur","year":"2000","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.192056-21","first-page":"482","volume-title":"The pathogenesis of ovarian hyperstimulation syndrome: In vivo studies investigating the role of interleukin-1 beta, interleukin-6, and vascular endothelial growth factor","author":"Pellicer","year":"1999","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.192056-22","first-page":"1967","volume-title":"Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor\/vascular permeability factor in human granulosa cells: Importance in ovarian hyperstimulation syndrome","author":"Neulen","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0974-1208.192056-23","first-page":"141","volume-title":"The lutropin\/choriogonadotropin receptor, a 2002 perspective","author":"Ascoli","year":"2002","journal-title":"Endocr Rev"},{"key":"key-10.4103\/0974-1208.192056-24","first-page":"CD003719","volume-title":"Recombinant versus urinary human chorionic gonadotrophin for ovulation induction in assisted conception","author":"Al-Inany","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/0974-1208.192056-25","first-page":"124","volume-title":"Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: From theory to practice","author":"La","year":"2014","journal-title":"Hum Reprod Update"},{"key":"key-10.4103\/0974-1208.192056-26","first-page":"32","volume-title":"Predicting and preventing ovarian hyperstimulation syndrome (OHSS): The need for individualized not standardized treatment","author":"Fiedler","year":"2012","journal-title":"Reprod Biol Endocrinol"},{"key":"key-10.4103\/0974-1208.192056-27","first-page":"1095","volume-title":"Low-dose gonadotrophin therapy for induction of ovulation in 100 women with polycystic ovary syndrome","author":"Hamilton-Fairley","year":"1991","journal-title":"Hum Reprod"},{"key":"key-10.4103\/0974-1208.192056-28","first-page":"CD001750","volume-title":"Gonadotrophin-releasing hormone antagonists for assisted conception","author":"Al-Inany","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/0974-1208.192056-29","first-page":"841","volume-title":"Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization","author":"Schmidt","year":"2004","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.192056-30","first-page":"475","volume-title":"Ovarian hyperstimulation syndrome prevention strategies: Reducing the human chorionic gonadotropin trigger dose","author":"Kashyap","year":"2010","journal-title":"Semin Reprod Med"},{"key":"key-10.4103\/0974-1208.192056-31","first-page":"480","volume-title":"Time to revolutionize the triggering of ovulation","author":"Emperaire","year":"2004","journal-title":"Reprod Biomed Online"},{"key":"key-10.4103\/0974-1208.192056-32","first-page":"CD006105","volume-title":"Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome","author":"Tso","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/0974-1208.192056-33","first-page":"547","volume-title":"Coasting for the prevention of ovarian hyperstimulation syndrome: Much ado about nothing?","author":"Garcia-Velasco","year":"2006","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.192056-34","first-page":"CD002811","volume-title":"Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome","author":"D\u2032Angelo","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/0974-1208.192056-35","first-page":"1111","volume-title":"Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting","author":"DiLuigi","year":"2010","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.192056-36","first-page":"1573","volume-title":", Veeck LL, Toner JP, Oehninger S, Muasher SJ.Cryopreservation of all prezygotes in patients at risk of severe hyperstimulation does not eliminate the syndrome, but the chances of pregnancy are excellent with subsequent frozen-thaw transfers","author":"Queenan","year":"1997","journal-title":"Hum Reprod"},{"key":"key-10.4103\/0974-1208.192056-37","first-page":"CD009154","volume-title":"Luteal phase support for assisted reproduction cycles","author":"van","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/0974-1208.192056-38","first-page":"255","volume-title":"Ovarian hyperstimulation syndrome: A current survey","author":"Schenker","year":"1978","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.192056-39","first-page":"CD001302","volume-title":"Intra-venous fluids for the prevention of severe ovarian hyperstimulation syndrome","author":"Youssef","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/0974-1208.192056-40","first-page":"CD008605","volume-title":"Cabergoline for preventing ovarian hyperstimulation syndrome","author":"Tang","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/0974-1208.192056-41","first-page":"664","volume-title":"Cabergoline for the prevention of ovarian hyperstimulation syndrome: Systematic review and meta-analysis of randomized controlled trials","author":"Leitao","year":"2014","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.192056-42","first-page":"86","volume-title":"A potential novel strategy, inhibition of vasopressin-induced VEGF secretion by relcovaptan, for decreasing the incidence of ovarian hyperstimulation syndrome in the hyperstimulated rat model","author":"Cenksoy","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"key-10.4103\/0974-1208.192056-43","first-page":"309","volume-title":"Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells","author":"Nauck","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"key-10.4103\/0974-1208.192056-44","first-page":"165","volume-title":"The induction of LH surge and oocyte maturation by GnRH analogue (Buserelin) in women undergoing ovarian stimulation for in vitro fertilization","author":"Itskovitz","year":"1988","journal-title":"Gynecol Endocrinol"},{"key":"key-10.4103\/0974-1208.192056-45","first-page":"2389","volume-title":"GnRHa to trigger final oocyte maturation: A time to reconsider","author":"Humaidan","year":"2009","journal-title":"Hum Reprod"},{"key":"key-10.4103\/0974-1208.192056-46","first-page":"2593","volume-title":"An OHSS-free clinic by segmentation of IVF treatment","author":"Devroey","year":"2011","journal-title":"Hum Reprod"},{"key":"key-10.4103\/0974-1208.192056-47","first-page":"CD008046","volume-title":"Gonadotropinreleasing hormone agonist versus HCG for oocyte triggering in antagonistassisted reproductive technology","author":"Youssef","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/0974-1208.192056-48","first-page":"1976","volume-title":"A randomised controlled study of human day 3 embryo cryopreservation by slow freezing or vitrification: Vitrification is associated with higher survival, metabolism and blastocyst formation","author":"Balaban","year":"2008","journal-title":"Hum Reprod"},{"key":"key-10.4103\/0974-1208.192056-49","first-page":"368","volume-title":"Obstetric and perinatal outcomes in singleton pregnancies resulting from the transfer of frozen thawed versus fresh embryos generated through in vitro fertilization treatment: A systematic review and meta-analysis","author":"Maheshwari","year":"2012","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.192056-50","first-page":"530","volume-title":"Implantation in assisted reproduction: A look at endometrial receptivity","author":"Fatemi","year":"2013","journal-title":"Reprod Biomed Online"},{"key":"key-10.4103\/0974-1208.192056-51","first-page":"1260","volume-title":"Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: A prospective randomized trial","author":"Babayof","year":"2006","journal-title":"Hum Reprod"},{"key":"key-10.4103\/0974-1208.192056-52","first-page":"1348","volume-title":"Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: A prospective, observational proof-of-concept study","author":"Griesinger","year":"2007","journal-title":"Hum Reprod"},{"key":"key-10.4103\/0974-1208.192056-53","first-page":"1215","volume-title":"Triggering ovulation with gonadotropin-releasing hormone agonist in in vitro fertilization patients with polycystic ovaries does not cause ovarian hyperstimulation syndrome despite very high estradiol levels","author":"Manzanares","year":"2010","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.192056-54","first-page":"341","volume-title":"GnRH agonist for final oocyte maturation in GnRH antagonist co-treated IVF\/ICSI treatment cycles: Systematic review and meta-analysis","author":"Youssef","year":"2015","journal-title":"J Adv Res"},{"key":"key-10.4103\/0974-1208.192056-55","first-page":"486","volume-title":"GnRH agonist versus recombinant HCG in an oocyte donation programme: A randomized, prospective, controlled, assessor-blind study","author":"Melo","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"key-10.4103\/0974-1208.192056-56","first-page":"251","volume-title":"Ovulation triggering with GnRH agonist vs.hCG in the same egg donor population undergoing donor oocyte cycles with GnRH antagonist: A prospective randomized cross-over trial","author":"Sismanoglu","year":"2009","journal-title":"J Assist Reprod Genet"},{"key":"key-10.4103\/0974-1208.192056-57","first-page":"1358","volume-title":"No room for cancellation, coasting, or ovarian hyperstimulation syndrome in oocyte donation cycles","author":"Hern\u00e1ndez","year":"2009","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.192056-58","first-page":"1526","volume-title":"Differential regulation of VEGF after final oocyte maturation with GnRH agonist versus hCG: A rationale for OHSS reduction","author":"Cerrillo","year":"2009","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.192056-59","first-page":"2522","volume-title":"Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG","author":"Seyhan","year":"2013","journal-title":"Hum Reprod"},{"key":"key-10.4103\/0974-1208.192056-60","first-page":"552","volume-title":"Retrospective comparison of GnRH agonist trigger with HCG trigger in GnRH antagonist cycles in anticipated high-responders","author":"Datta","year":"2014","journal-title":"Reprod Biomed Online"},{"key":"key-10.4103\/0974-1208.192056-61","first-page":"1008","volume-title":"Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and \"freeze-all\" approach in GnRH antagonist protocol","author":"Fatemi","year":"2014","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.192056-62","first-page":"159","volume-title":"GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: A systematic review and meta-analysis","author":"Griesinger","year":"2006","journal-title":"Hum Reprod Update"}],"container-title":["Journal of Human Reproductive Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:28:43Z","timestamp":1786714123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0974-1208.192056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"alternative-id":["192056"],"URL":"https:\/\/doi.org\/10.4103\/0974-1208.192056","relation":{},"ISSN":["0974-1208"],"issn-type":[{"value":"0974-1208","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}